Macrogenics (NASDAQ: MGNX) reported Q4 EPS of ($0.15), in-line with the analyst estimate of ($0.15). Revenue for the quarter came in at $58.8 million versus the consensus estimate of $34.13 million.

For earnings history and earnings-related data on Macrogenics (MGNX) click here.